Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1995-06-02
1999-01-19
Guzo, David
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
424 932, 424 936, 4351723, A61K 9127, A61K 48001
Patent
active
058611711
ABSTRACT:
A composition for genetic manipulation which comprises a liposome comprised of lipid material, and adeno-associated viral (AAV) material. Typically, the AAV material is plasmid, and comprises a terminal repeat of the AAV genome. Methods are disclosed for introducing genetic material into cells by use of AAV liposomes. Accordingly, genetic material was introduced and integrated into stem cells, T cells, primary tumor cells, or tumor cell lines.
REFERENCES:
patent: 4394448 (1983-07-01), Szoka, Jr. et al.
patent: 4935372 (1990-06-01), Goh
patent: 5126132 (1992-06-01), Rosenberg
patent: 5139941 (1992-08-01), Muzyczka et al.
patent: 5198344 (1993-03-01), Croop et al.
patent: 5250431 (1993-10-01), Rudd et al.
patent: 5252479 (1993-10-01), Srivastava et al.
patent: 5436146 (1995-07-01), Shenk et al.
patent: 5587308 (1996-12-01), Carter et al.
Faller, D.V. and Baltimore, D., J. Virol., 49:269-272 (1984).
Felgner, P.L. et al., Proc. Natl. Acad. Sci. USA, 84:7413-7417 (1987).
Malone, R. et al., Proc. Natl. Acad. Sci. USA, 86:6077-6081.
Shaefer-Ridder, M. et al., Science, 215:166-168 (1982).
Stribling, R. et al., Proc. Natl. Acad. Sci. USA, 89:11277-11281 (1992).
Zhu, N. et al., Science, 261:209-211 (1993).
Stewart, M.J. et al., Human Gene Therapy, 3:267-275 (1992).
Felgner et al., Nature, 337:387-388 (1989).
Wang et al., Proc. Natl. Acad. Sci., 84, 7851-7855 (1987).
Kotin, R.M. et al., Proc. Natl. Acad. Sci., 87:2211-2215 (1990).
Hermonat, P.L. et al., J. Virol., 51:329-339 (1984).
Graham, F.L. et al., J. Gen. Virol., 36:59-72 (1977).
Hermonat, P.L. and Muzyczka, N., Proc. Natl. Acad. Sci. USA, 81:6466-6470.
Tratschin, J.D. et al., Mol. Cell. Biol., 5:3251-3260 (1985).
Philip, R. et al., Mol. Cell. Biol., 14(4):2411-2418 (1994).
Lebkowski, J.S. et al., Mol. Cell. Biol., 8:3988-3996 (1988).
West, W.H. et al., N. Engl. J. Med., 316:898 (1987).
Topolian, S.L. et al., J. Immunol. Methods, 102:127-141 (1987).
Marshall, Science, 269:1050-1055 (1995).
Hodgson, Exp. Opin. Ther. Pat., 5(5):459-468 (1995).
Miller et al., F.A.S.E.B., 9:190-199 (1995).
Culver et al., T.I.G., 10(5):174-178 (1994).
Rosenberg et al., Annals Surg., 218(4):455-464 (1993).
Gutierrez et al., Lancet, 339:715-721 (1992).
Oken, Am. J. Clin. Oncol. (CCT), 5:649-655 (1982).
Rosenberg, S., Cancer Res., (Suppl.) 51, 5074s-5079s (1991).
Crystal, R., Science, 270, 404-410 (1995).
Mulligan, R., Science, 260, 926-930 (1993).
Coghlan et al., New Scientist, 14-15 (1995).
Brown, D., The Washington Post, A22 (Dec. 8, 1995).
Barinaga, M., Science, 266, 1326 (1994).
Cohen, J.S., Trends in Biotechnology, 10:87-91 (1992).
Dropulic, B. et al., Human Gene Therapy, 5:927-939 (1994).
Pizzo, P.A. et al., Clinical Infectious Diseases, 19:177-196 (1994).
Kern, E.R., Antiviral Agents and Viral Diseases of Man, 3rd edition, G.J. Galasso et al. editors, pp. 94-95 (1990).
Sacramento Bee, p. A22 (Feb. 26, 1994).
Sacramentao Bee, p. B5 (Nov. 29, 1991).
Collins, H., Philadelphia Inquirer, p. A01 (Mar. 6, 1993).
DeNoon, D.J., IAC Newsletter, DB Accession No. 02944476 (1995).
Tartour, E. et al., Biomedicine and Pharmacotherapy, 46:473-484 (1992).
Friedmann, T., TIG, 10(6), 210-214 (1994).
Rose et al., Biotechniques, vol. 10, No. 4, pp. 520-525, 1991.
Innes et al., "Cationic Liposomes (Lipofectin) Mediate Retroviral Infection in the Absence of Specific Receptors", J. Virol., vol. 64, No. 2, 1990, pp. 957-961.
Philip et al., "In vivo Gene Delivery", J. Biol. Chem., vol. 268, No. 22 Aug. 5, 1993, pp. 16087-16090.
Hug et al., "Liposome for the Transformation of Eukozotic Cells", Biochem. et Biophys. Acta, vol. 1097, 1991, pp. 1-17.
Lebkowski Jane
Philip Ramila
Guzo David
Rhone-Poulenc Rorer Pharmaceuticals Inc.
LandOfFree
Adeno-associated viral (AAV) liposomes and methods related there does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adeno-associated viral (AAV) liposomes and methods related there, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adeno-associated viral (AAV) liposomes and methods related there will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1245077